Evidence map›Paper›PMID 34504068›Full record

ArticleNature communications2021

Structural basis for the tryptophan sensitivity of TnaC-mediated ribosome stalling.

Anne-Xander van der Stel, Emily R Gordon, Arnab Sengupta, Allyson K Martínez, Dorota Klepacki, Thomas N Perry, Alba Herrero Del Valle, Nora Vázquez-Laslop, Matthew S Sachs, Luis R Cruz-Vera and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Anne-Xander van der StelUniv. Bordeaux, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, ARNA, UMR 5320, U1212, Institut Européen de Chimie et Biologie, Pessac, France.
Emily R GordonDepartment of Biological Sciences, University of Alabama in Huntsville, Huntsville, AL, USA.ORCID http://orcid.org/0000-0002-0838-7110
Arnab SenguptaDepartment of Biological Sciences, University of Alabama in Huntsville, Huntsville, AL, USA.ORCID http://orcid.org/0000-0002-8548-9428
Allyson K MartínezDepartment of Biology, Texas A&M University, College Station, TX, USA.
Dorota KlepackiCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL, USA.
Thomas N PerryUniv. Bordeaux, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, ARNA, UMR 5320, U1212, Institut Européen de Chimie et Biologie, Pessac, France.
Alba Herrero Del ValleUniv. Bordeaux, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, ARNA, UMR 5320, U1212, Institut Européen de Chimie et Biologie, Pessac, France.ORCID http://orcid.org/0000-0001-8153-6146
Nora Vázquez-LaslopCenter for Biomolecular Sciences, University of Illinois at Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-2256-693X
Matthew S SachsDepartment of Biology, Texas A&M University, College Station, TX, USA. msachs@bio.tamu.edu.ORCID http://orcid.org/0000-0001-9891-9223
Luis R Cruz-VeraDepartment of Biological Sciences, University of Alabama in Huntsville, Huntsville, AL, USA. lrc0002@uah.edu.ORCID http://orcid.org/0000-0002-4593-9957
C Axel InnisUniv. Bordeaux, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, ARNA, UMR 5320, U1212, Institut Européen de Chimie et Biologie, Pessac, France. axel.innis@inserm.fr.ORCID http://orcid.org/0000-0003-3153-9490
Université de Bordeaux · FRUniversity of Alabama in Huntsville · USTexas A&M University · USUniversity of Illinois Chicago · US

Funding

CONTROL OF ARG-2 GENE EXPRESSION IN NEUROSPORAR01GM047498 · NIGMS · TEXAS A&M UNIVERSITY · PI SACHS, MATTHEW STEVEN · 1997 to 2009
$2.8M
NIGMS NIH HHS R01 GM047498
6 · The paper itself

Abstract

Free L-tryptophan (L-Trp) stalls ribosomes engaged in the synthesis of TnaC, a leader peptide controlling the expression of the Escherichia coli tryptophanase operon. Despite extensive characterization, the molecular mechanism underlying the recognition and response to L-Trp by the TnaC-ribosome complex remains unknown. Here, we use a combined biochemical and structural approach to characterize a TnaC variant (R23F) with greatly enhanced sensitivity for L-Trp. We show that the TnaC-ribosome complex captures a single L-Trp molecule to undergo termination arrest and that nascent TnaC prevents the catalytic GGQ loop of release factor 2 from adopting an active conformation at the peptidyl transferase center. Importantly, the L-Trp binding site is not altered by the R23F mutation, suggesting that the relative rates of L-Trp binding and peptidyl-tRNA cleavage determine the tryptophan sensitivity of each variant. Thus, our study reveals a strategy whereby a nascent peptide assists the ribosome in detecting a small metabolite.

Indexed as

Gene Expression Regulation, BacterialPeptide Chain Initiation, TranslationalAmino Acid SubstitutionBinding SitesCryoelectron MicroscopyEscherichia coliEscherichia coli ProteinsModels, MolecularMutationOperonPeptide Chain Termination, TranslationalPeptide Termination FactorsProtein BindingProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandProtein Interaction Domains and MotifsEscherichia coli ProteinsPeptide Termination FactorsRNA, Transfer, Amino AcyltnaC protein, E colitRNA, peptidyl-Tryptophan

Identifiers

PMID34504068
PMCPMC8429421
OpenAlexW3196570262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.